Ignite Creation Date:
2024-05-05 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00343109
Status:
COMPLETED
Last Update Posted:
2020-02-12
First Post:
2006-06-20
Brief Title:
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer
Sponsor:
University of Washington
Organization:
University of Washington
Organization Data
Organization:
University of Washington
Class:
OTHER
Study ID:
6166 FHUWCC ID
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Washington
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |